Sfoglia per Autore
Iliopsoas bursitis in rheumatoid arthritis.
1993 Generini S;Matucci Cerinic M
Somatostatin-induced modulation of inflammation in experimental arthritis
1995 M. MATUCCI-CERINIC; F. BORRELLI; S. GENERINI; A. CANTELMO; I. MARCUCCI; F. MARTELLI; P. ROMAGNOLI; S. BACCI; A. CONZ; P. MARINELLI; S. MARABINI
Increased circulating nerve growth factor is directly correlated with disease activity in juvenile chronic arthritis.
1996 Falcini F;Matucci Cerinic M;Lombardi A;Generini S;Pignone A;Tirassa P;Ermini M;Lepore L;Partsch G;Aloe L
The nervous system in systemic sclerosis (scleroderma). Clinical features and pathogenetic mechanisms.
1996 Cerinic MM;Generini S;Pignone A;Casale R
Nerve growth factor circulating levels are increased in Kawasaki disease: correlation with disease activity and reduced angiotensin converting enzyme levels.
1996 Falcini F;Cerinic MM;Ermini M;Generini S;Lombardi A;Pignone A;Leoncini G;Tirassa P;Aloe L
Peripheral nervous system involvement in systemic sclerosis: the median nerve as target structure.
1996 Lori S;Matucci Cerinic M;Casale R;Generini S;Lombardi A;Pignone A;Scaletti C;Gangemi PF;Cagnoni M
Raynaud's phenomenon and systemic sclerosis.
1996 Generini S;Kahaleh B;Matucci Cerinic M;Pignone A;Lombardi A;Ohtsuka T
Clinical and laboratory features and disease outcome of kawasaki disease: the analysis of our experience and literature review.
1997 Generini S;Ermini M;Taccetti G;Trapani S;Cerinic MM;Falcini F
Urokinase-type plasminogen activator is the main plasminogen activator produced by synoviocytes of osteoarthritis and rheumatoid arthitis
1997 LOMBARDI A.; MATUCCI CERINIC M.; LEONCINI G.; MOGGI PIGNONE A.; GENERINI S.; CAROSSINO A.M.; SCALETTI C.; PARTSCH G.; DEL ROSSO M.; CAGNONI M.
New approaches to Raynaud's phenomenon [corrected].
1997 Cerinic MM;Generini S;Pignone A
Neuropeptides and steroid hormones in arthritis.
1998 Cerinic MM;Konttinen Y;Generini S;Cutolo M
Anti-endothelial cell antibodies in systemic sclerosis: significant association with vascular involvement and alveolo-capillary impairment.
1998 Pignone A;Scaletti C;Matucci Cerinic M;Vázquez-Abad D;Meroni PL;Del Papa N;Falcini F;Generini S;Rothfield N;Cagnoni M
Synoviocytes from osteoarthritis and rheumatoid arthritis produce plasminogen activators and plasminogen activator inhibitor-1 and display u-PA receptors on their surface.
1998 Matucci Cerinic M; Generini S; Partsch G; Moggi Pignone A; Dini G; Konttinen YT; Del Rosso M.
Raynaud's phenomenon and vascular disease in systemic sclerosis.
1999 Generini S;Matucci Cerinic M
Are Angiotensin Converting Enzyme and von Willebrand factor circulating levels useful surrogate parameters to monitor disease activity in Kawasaki disease?
1999 Falcini F;Generini S;Pignone A;Leoncini G;Cimaz R;Partsch G;Matucci Cerinic M
Vasculitides secondary to systemic diseases.
1999 Del Rosso A;Generini S;Pignone A;Matucci Cerinic M
Oxidative stress in Systemic Sclerosis.
1999 Simonini G; Matucci Cerinic M; Generini S; Zoppi M; Anichini M; Cesaretti S; Pignone A; Falcini F; Lotti T; Cagnoni M.
Discrepant expression of neprilysin on fibroblasts in diffuse systemic sclerosis.
1999 MATUCCI CERINIC M; IANNONE F; CAROSSINO A.M.; MOGGI PIGNONE A; LEONCINI G; GENERINI S; LAPADULA G; CAGNONI M.
Reduction of bcl-2 in T cells during immunosuppressive therapy in patients with severe juvenile onset systemic lupus erythematosus.
1999 Falcini F;Azzari C;Gelli VA;Luchetti M;Gabrielli A;Calzolari A;Pignone A;Generini S;Matucci Cerinic M
Systemic sclerosis. A clinical overview.
1999 Generini S;Fiori G;Moggi Pignone A;Matucci Cerinic M;Cagnoni M
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile